Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Fate of the capping agent of biologically produced gold nanoparticles and adsorption of enzymes onto their surface

P. Pourali, V. Dzmitruk, M. Pátek, E. Neuhöferová, M. Svoboda, V. Benson

. 2023 ; 13 (1) : 4916. [pub] 20230325

Language English Country England, Great Britain

Document type Journal Article

Enzymotherapy based on DNase I or RNase A has often been suggested as an optional strategy for cancer treatment. The efficacy of such procedures is limited e.g. by a short half-time of the enzymes or a low rate of their internalization. The use of nanoparticles, such as gold nanoparticles (AuNPs), helps to overcome these limits. Specifically, biologically produced AuNPs represent an interesting variant here due to naturally occurring capping agents (CA) on their surface. The composition of the CA depends on the producing microorganism. CAs are responsible for the stabilization of the nanoparticles, and promote the direct linking of targeting and therapeutic molecules. This study provided proof of enzyme adsorption onto gold nanoparticles and digestion efficacy of AuNPs-adsorbed enzymes. We employed Fusarium oxysporum extract to produce AuNPs. These nanoparticles were round or polygonal with a size of about 5 nm, negative surface charge of about - 33 mV, and maximum absorption peak at 530 nm. After the adsorption of DNAse I, RNase A, or Proteinase K onto the AuNPs surface, the nanoparticles exhibited shifts in surface charge (values between - 22 and - 13 mV) and maximum absorption peak (values between 513 and 534 nm). The ability of AuNP-enzyme complexes to digest different targets was compared to enzymes alone. We found a remarkable degradation of ssDNA, and dsDNA by AuNP-DNAse I, and a modest degradation of ssRNA by AuNP-RNase A. The presence of particular enzymes on the AuNP surface was proved by liquid chromatography-mass spectrometry (LC-MS). Using SDS-PAGE electrophoresis, we detected a remarkable digestion of collagen type I and fibrinogen by AuNP-proteinase K complexes. We concluded that the biologically produced AuNPs directly bound DNase I, RNase A, and proteinase K while preserving their ability to digest specific targets. Therefore, according to our results, AuNPs can be used as effective enzyme carriers and the AuNP-enzyme conjugates can be effective tools for enzymotherapy.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23003749
003      
CZ-PrNML
005      
20230425140849.0
007      
ta
008      
230418s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-023-31792-5 $2 doi
035    __
$a (PubMed)36966192
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Pourali, Parastoo $u Institute of Microbiology, Czech Academy of Sciences, 142 20, Prague, Czech Republic
245    10
$a Fate of the capping agent of biologically produced gold nanoparticles and adsorption of enzymes onto their surface / $c P. Pourali, V. Dzmitruk, M. Pátek, E. Neuhöferová, M. Svoboda, V. Benson
520    9_
$a Enzymotherapy based on DNase I or RNase A has often been suggested as an optional strategy for cancer treatment. The efficacy of such procedures is limited e.g. by a short half-time of the enzymes or a low rate of their internalization. The use of nanoparticles, such as gold nanoparticles (AuNPs), helps to overcome these limits. Specifically, biologically produced AuNPs represent an interesting variant here due to naturally occurring capping agents (CA) on their surface. The composition of the CA depends on the producing microorganism. CAs are responsible for the stabilization of the nanoparticles, and promote the direct linking of targeting and therapeutic molecules. This study provided proof of enzyme adsorption onto gold nanoparticles and digestion efficacy of AuNPs-adsorbed enzymes. We employed Fusarium oxysporum extract to produce AuNPs. These nanoparticles were round or polygonal with a size of about 5 nm, negative surface charge of about - 33 mV, and maximum absorption peak at 530 nm. After the adsorption of DNAse I, RNase A, or Proteinase K onto the AuNPs surface, the nanoparticles exhibited shifts in surface charge (values between - 22 and - 13 mV) and maximum absorption peak (values between 513 and 534 nm). The ability of AuNP-enzyme complexes to digest different targets was compared to enzymes alone. We found a remarkable degradation of ssDNA, and dsDNA by AuNP-DNAse I, and a modest degradation of ssRNA by AuNP-RNase A. The presence of particular enzymes on the AuNP surface was proved by liquid chromatography-mass spectrometry (LC-MS). Using SDS-PAGE electrophoresis, we detected a remarkable digestion of collagen type I and fibrinogen by AuNP-proteinase K complexes. We concluded that the biologically produced AuNPs directly bound DNase I, RNase A, and proteinase K while preserving their ability to digest specific targets. Therefore, according to our results, AuNPs can be used as effective enzyme carriers and the AuNP-enzyme conjugates can be effective tools for enzymotherapy.
650    12
$a zlato $x chemie $7 D006046
650    12
$a kovové nanočástice $x chemie $7 D053768
650    _2
$a adsorpce $7 D000327
650    _2
$a pankreatická ribonukleasa $7 D012259
650    _2
$a endopeptidasa K $7 D019286
655    _2
$a časopisecké články $7 D016428
700    1_
$a Dzmitruk, Volha $u Center of Molecular Structure, Institute of Biotechnology, Czech Academy of Sciences, 252 50, Prague, Czech Republic
700    1_
$a Pátek, Miroslav $u Institute of Microbiology, Czech Academy of Sciences, 142 20, Prague, Czech Republic
700    1_
$a Neuhöferová, Eva $u Institute of Microbiology, Czech Academy of Sciences, 142 20, Prague, Czech Republic
700    1_
$a Svoboda, Milan $u Institute of Analytical Chemistry, Czech Academy of Sciences, 602 00, Brno, Czech Republic
700    1_
$a Benson, Veronika $u Institute of Microbiology, Czech Academy of Sciences, 142 20, Prague, Czech Republic. benson@biomed.cas.cz
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 13, č. 1 (2023), s. 4916
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36966192 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425140846 $b ABA008
999    __
$a ok $b bmc $g 1924431 $s 1189958
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 13 $c 1 $d 4916 $e 20230325 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20230418

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...